Logo image of SRI

STONERIDGE INC (SRI) Stock Fundamental Analysis

NYSE:SRI - New York Stock Exchange, Inc. - US86183P1021 - Common Stock - Currency: USD

5.68  -0.38 (-6.27%)

After market: 5.68 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SRI. SRI was compared to 81 industry peers in the Automobile Components industry. While SRI seems to be doing ok healthwise, there are quite some concerns on its profitability. SRI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SRI had negative earnings in the past year.
In the past year SRI had a positive cash flow from operations.
SRI had negative earnings in 4 of the past 5 years.
SRI had a positive operating cash flow in 4 of the past 5 years.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

SRI has a worse Return On Assets (-2.68%) than 80.25% of its industry peers.
SRI has a worse Return On Equity (-6.95%) than 77.78% of its industry peers.
SRI's Return On Invested Capital of 0.25% is on the low side compared to the rest of the industry. SRI is outperformed by 82.72% of its industry peers.
SRI had an Average Return On Invested Capital over the past 3 years of 1.22%. This is significantly below the industry average of 9.04%.
Industry RankSector Rank
ROA -2.68%
ROE -6.95%
ROIC 0.25%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

SRI has a Operating Margin of 0.17%. This is amonst the worse of the industry: SRI underperforms 82.72% of its industry peers.
In the last couple of years the Operating Margin of SRI has declined.
SRI has a Gross Margin of 21.33%. This is in the lower half of the industry: SRI underperforms 67.90% of its industry peers.
In the last couple of years the Gross Margin of SRI has declined.
Industry RankSector Rank
OM 0.17%
PM (TTM) N/A
GM 21.33%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRI is destroying value.
SRI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRI has more shares outstanding
The debt/assets ratio for SRI is higher compared to a year ago.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

SRI has an Altman-Z score of 2.40. This is not the best score and indicates that SRI is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.40, SRI perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
The Debt to FCF ratio of SRI is 8.14, which is on the high side as it means it would take SRI, 8.14 years of fcf income to pay off all of its debts.
SRI has a Debt to FCF ratio of 8.14. This is in the lower half of the industry: SRI underperforms 67.90% of its industry peers.
A Debt/Equity ratio of 0.80 indicates that SRI is somewhat dependend on debt financing.
SRI has a Debt to Equity ratio of 0.80. This is amonst the worse of the industry: SRI underperforms 80.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.14
Altman-Z 2.4
ROIC/WACC0.02
WACC10.45%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 2.39 indicates that SRI has no problem at all paying its short term obligations.
SRI's Current ratio of 2.39 is amongst the best of the industry. SRI outperforms 80.25% of its industry peers.
A Quick Ratio of 1.52 indicates that SRI should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.52, SRI belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.52
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

The earnings per share for SRI have decreased strongly by -264.29% in the last year.
Looking at the last year, SRI shows a decrease in Revenue. The Revenue has decreased by -8.90% in the last year.
The Revenue has been growing slightly by 1.71% on average over the past years.
EPS 1Y (TTM)-264.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-8.89%

3.2 Future

SRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.19% yearly.
Based on estimates for the next years, SRI will show a small growth in Revenue. The Revenue will grow by 2.99% on average per year.
EPS Next Y31.23%
EPS Next 2Y67.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.73%
Revenue Next 2Y2.99%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

SRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 15.20, the valuation of SRI can be described as correct.
SRI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SRI is more expensive than 60.49% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SRI to the average of the S&P500 Index (22.13), we can say SRI is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.2
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

SRI's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, SRI is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.34
EV/EBITDA 8.01
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SRI's earnings are expected to grow with 67.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.19%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SRI!.
Industry RankSector Rank
Dividend Yield N/A

STONERIDGE INC

NYSE:SRI (6/13/2025, 8:04:00 PM)

After market: 5.68 0 (0%)

5.68

-0.38 (-6.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners100.23%
Inst Owner Change7.7%
Ins Owners2.28%
Ins Owner Change9.24%
Market Cap158.19M
Analysts86.67
Price Target14.28 (151.41%)
Short Float %2.03%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-196.74%
Min EPS beat(2)-345.54%
Max EPS beat(2)-47.95%
EPS beat(4)1
Avg EPS beat(4)37.77%
Min EPS beat(4)-397.03%
Max EPS beat(4)941.58%
EPS beat(8)4
Avg EPS beat(8)26.56%
EPS beat(12)6
Avg EPS beat(12)30.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.68%
Max Revenue beat(2)2.92%
Revenue beat(4)1
Avg Revenue beat(4)-2.7%
Min Revenue beat(4)-7.81%
Max Revenue beat(4)2.92%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)2.18%
Revenue beat(16)10
Avg Revenue beat(16)3.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28%
EPS NY rev (1m)0%
EPS NY rev (3m)-420%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.2
P/S 0.18
P/FCF 6.34
P/OCF 3.19
P/B 0.63
P/tB 0.89
EV/EBITDA 8.01
EPS(TTM)-0.51
EYN/A
EPS(NY)0.37
Fwd EY6.58%
FCF(TTM)0.9
FCFY15.78%
OCF(TTM)1.78
OCFY31.31%
SpS31.85
BVpS9.09
TBVpS6.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -6.95%
ROCE 0.32%
ROIC 0.25%
ROICexc 0.3%
ROICexgc 0.37%
OM 0.17%
PM (TTM) N/A
GM 21.33%
FCFM 2.81%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)1.22%
ROIC(5y)N/A
ROICexc(3y)1.34%
ROICexc(5y)N/A
ROICexgc(3y)1.64%
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-44.52%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.72%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.14
Debt/EBITDA 5.77
Cap/Depr 72.91%
Cap/Sales 2.77%
Interest Coverage 0.11
Cash Conversion 140.56%
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.52
Altman-Z 2.4
F-Score4
WACC10.45%
ROIC/WACC0.02
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-264.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y31.23%
EPS Next 2Y67.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.9%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-8.89%
Revenue Next Year-3.73%
Revenue Next 2Y2.99%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.51%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year178.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y247.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y184.12%
OCF growth 3YN/A
OCF growth 5Y14.27%